Nuvation Bio NUVB Other
Other at other companies
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther.
The official record: Nuvation Bio’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvation Bio's other.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvation Bio's other?
- Nuvation Bio (NUVB) reported other of $1.66M in Q4 2025.
- What is the long-term trend for Nuvation Bio's other?
- Over 5 years (2020 to 2025), Nuvation Bio's other has grown at a 25.6% compound annual growth rate (CAGR), from $529K to $1.66M.
- What does other mean?
- This captures miscellaneous deferred tax assets resulting from temporary differences between the carrying amount of assets or liabilities in the financial statements and their tax bases. It includes various tax-deductible expenses that are recognized in the financial statements in a different period than they are recognized for tax purposes. This metric helps investors understand the broader tax planning and deferred tax position of the company beyond specific R&D or lease-related items.